The United States Leukemia Therapeutics Market is benefiting from strong research and development activities, clinical trials, precision medicine initiatives, and the availability of established and emerging therapies. Continued advancements in molecular diagnostics, cellular therapies, and personalized treatment strategies are expected to strengthen therapeutic opportunities across the...